Pure Global

HAV IgM ELISA - India CDSCO Medical Device Registration

HAV IgM ELISA is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2019/000307_dd3bba9b889001cb5c066a3ad3b0ec30_5b75f06e8ce7a750869b425d51641242. This device is marketed under the brand name RecombiLISA. The license holder is Athenese-Dx Private Limited, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
HAV IgM ELISA
UID: IMP/IVD/2019/000307_dd3bba9b889001cb5c066a3ad3b0ec30_5b75f06e8ce7a750869b425d51641242

Brand Name

RecombiLISA

Device Class

Class B

Approving Authority

CDSCO

Product Information

The HAV IgM ELISA is a solid-phase enzyme-linked immunosorbent assay for the qualitative detection of IgM to hepatitis A virus in human serum or plasma. It is intended for professional use only as an aid in the diagnosis of infection with HAV

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing